Ecallantide (TFA)

Ecallantide (DX-88) TFA is a specific recombinant plasma kallikrein inhibitor. Ecallantide inhibits the production of bradykinin. Ecallantide may be used to prevent acute attacks of angioedema[1].

Product Specifications

CAS Number

[9007-83-4]

Product Name Alternative

DX-88 (TFA)

UNSPSC

12352209

Target

Kallikrein

Type

Peptides

Related Pathways

Immunology/Inflammation

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/ecallantide-tfa.html

Purity

98.94

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

CC[C@@H]([C@H]1C(N[C@@H](CC2=CC=C(O)C=C2)C(NCC(NCC(N[C@H]3CSSC[C@H]4C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CC5=CN=CN5)C(N6CCC[C@H]6C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC7=CNC8=CC=CC=C87)C(N[C@@H](CC9=CC=CC=C9)C(N[C@@H](CC%10=CC=CC=C%10)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@H](CC)C)C(N[C@@H](CC%11=CC=CC=C%11)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC%12=CC=CC=C%12)C(N1)=O)=O)=O)=O)CSSCC(NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CCC(O)=O)NC([C@H](CC%13=CC=CC=C%13)NC([C@H](CCCNC(N)=N)NC([C@H](CC(N)=O)NC([C@H](CCC(N)=O)NC([C@H](CC(N)=O)NC(CNC([C@H](CCC(O)=O)NC3=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CC(O)=O)=O)CCCNC(N)=N)=O)[C@H](O)C)=O)CSSC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](N)CCC(O)=O)=O)C)=O)CCSC)=O)CC%14=CN=CN%14)=O)CO)=O)CC%15=CC=CC=C%15)=O)C(N[C@@H](C)C(N[C@@H](CC%16=CC=CC=C%16)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(NCC(N%17CCC[C@H]%17C(N4)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C.OC(C(F)(F)F)=O.[x]

Molecular Formula

C305H442N88O91S8.xC2HF3O2

Molecular Weight

7053.81 (free base)

References & Citations

[1]Martello JL, et al. Ecallantide for treatment of acute attacks of hereditary angioedema. Am J Health Syst Pharm. 2012 Apr 15;69 (8) :651-7. [Content Brief]